Gregory L. Kedderis

1.8k total citations
43 papers, 1.4k citations indexed

About

Gregory L. Kedderis is a scholar working on Pharmacology, Cancer Research and Molecular Biology. According to data from OpenAlex, Gregory L. Kedderis has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 20 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Gregory L. Kedderis's work include Carcinogens and Genotoxicity Assessment (19 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Gregory L. Kedderis is often cited by papers focused on Carcinogens and Genotoxicity Assessment (19 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Gregory L. Kedderis collaborates with scholars based in United States, United Kingdom and Germany. Gregory L. Kedderis's co-authors include Cheryl A. Mugford, Gerald T. Miwa, Renu Batra, Douglas E. Rickert, John C. Lipscomb, Susan Sumner, Timothy R. Fennell, Albert P. Li, Byron E. Butterworth and Dennis R. Koop and has published in prestigious journals such as The Science of The Total Environment, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Gregory L. Kedderis

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory L. Kedderis United States 21 440 440 358 292 157 43 1.4k
Erik J. Søderlund United States 22 626 1.4× 263 0.6× 454 1.3× 318 1.1× 139 0.9× 61 1.2k
Michael A. Pereira United States 25 445 1.0× 307 0.7× 759 2.1× 254 0.9× 290 1.8× 66 2.0k
Yasuo Ohno Japan 22 273 0.6× 365 0.8× 731 2.0× 285 1.0× 142 0.9× 68 1.7k
J.A. Beamand United Kingdom 20 263 0.6× 532 1.2× 566 1.6× 241 0.8× 225 1.4× 34 1.4k
Wolfgang W. Huber Austria 22 375 0.9× 214 0.5× 829 2.3× 205 0.7× 184 1.2× 32 2.0k
Charlene A. McQueen United States 24 738 1.7× 234 0.5× 755 2.1× 379 1.3× 143 0.9× 66 1.8k
William M. Bracken United States 23 467 1.1× 579 1.3× 778 2.2× 475 1.6× 243 1.5× 42 2.6k
Jos Bessems Netherlands 23 216 0.5× 784 1.8× 341 1.0× 576 2.0× 223 1.4× 52 2.1k
Matthew Bryant United States 30 705 1.6× 230 0.5× 807 2.3× 640 2.2× 171 1.1× 76 2.5k
P. Lesca France 23 378 0.9× 688 1.6× 668 1.9× 420 1.4× 423 2.7× 68 1.7k

Countries citing papers authored by Gregory L. Kedderis

Since Specialization
Citations

This map shows the geographic impact of Gregory L. Kedderis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory L. Kedderis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory L. Kedderis more than expected).

Fields of papers citing papers by Gregory L. Kedderis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory L. Kedderis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory L. Kedderis. The network helps show where Gregory L. Kedderis may publish in the future.

Co-authorship network of co-authors of Gregory L. Kedderis

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory L. Kedderis. A scholar is included among the top collaborators of Gregory L. Kedderis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory L. Kedderis. Gregory L. Kedderis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kedderis, Gregory L., et al.. (2013). Cytotoxicity of naphthalene toward cells from target and non-target organs in vitro. Chemico-Biological Interactions. 209. 85–95. 9 indexed citations
2.
Schlosser, Paul M., Gregory L. Kedderis, Mary Beth Genter, et al.. (2012). Application of an Updated Physiologically Based Pharmacokinetic Model for Chloroform to Evaluate CYP2E1-Mediated Renal Toxicity in Rats and Mice. Toxicological Sciences. 131(2). 360–374. 23 indexed citations
3.
Kedderis, Gregory L., et al.. (2006). Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes. Chemico-Biological Interactions. 161(2). 139–145. 14 indexed citations
4.
Lipscomb, John C., et al.. (2003). The Impact of Cytochrome P450 2E1‐Dependent Metabolic Variance on a Risk‐Relevant Pharmacokinetic Outcome in Humans. Risk Analysis. 23(6). 1221–1238. 49 indexed citations
5.
Ward, Elizabeth M., Paul A. Schulte, Aaron Blair, et al.. (2002). Priorities for Development of Research Methods in Occupational Cancer. Environmental Health Perspectives. 111(1). 1–12. 3 indexed citations
6.
Sprankle, Catherine S., Jeffrey M. Peters, Gregory L. Kedderis, et al.. (1999). Metabolism of Chloroform by Cytochrome P450 2E1 Is Required for Induction of Toxicity in the Liver, Kidney, and Nose of Male Mice. Toxicology and Applied Pharmacology. 160(2). 120–126. 89 indexed citations
7.
Fransson-Steen, Ronny, Thomas L. Goldsworthy, Gregory L. Kedderis, & Robert R. Maronpot. (1997). Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice. Toxicology. 118(2-3). 195–204. 45 indexed citations
8.
Kedderis, Gregory L.. (1997). Pharmacokinetics of Drug Interactions. Advances in pharmacology. 43. 189–203. 12 indexed citations
9.
Li, Albert P. & Gregory L. Kedderis. (1997). Primary hepatocyte culture as an experimental model for the evaluation of interactions between xenobiotics and drug-metabolizing enzymes. Chemico-Biological Interactions. 107(1-2). 1–3. 7 indexed citations
10.
Kedderis, Gregory L., et al.. (1996). Refinement and Verification of the Physiologically Based Dosimetry Description for Acrylonitrile in Rats. Toxicology and Applied Pharmacology. 140(2). 422–435. 16 indexed citations
11.
Kedderis, Gregory L.. (1996). Biochemical Basis of Hepatocellular Injury. Toxicologic Pathology. 24(1). 77–83. 52 indexed citations
12.
Kedderis, Gregory L., et al.. (1996). Prediction of Furan Pharmacokinetics from Hepatocyte Studies: Comparison of Bioactivation and Hepatic Dosimetry in Rats, Mice, and Humans. Toxicology and Applied Pharmacology. 140(1). 124–130. 61 indexed citations
13.
Butterworth, Byron E., Michael V. Templin, Susan J. Borghoff, et al.. (1995). The role of regenerative cell proliferation in chloroform-induced cancer. Toxicology Letters. 82-83. 23–26. 23 indexed citations
14.
Kedderis, Gregory L., Renu Batra, & Dennis R. Koop. (1993). Epoxidation of acrylonitrile by rat and human cytochromes P450. Chemical Research in Toxicology. 6(6). 866–871. 44 indexed citations
15.
Kedderis, Gregory L., et al.. (1993). Rodent tissue distribution of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Toxicology Letters. 69(1). 25–30. 10 indexed citations
16.
Fennell, Timothy R., Gregory L. Kedderis, & Susan Sumner. (1991). Urinary metabolites of [1,2,3-13C]acrylonitrile in rats and mice detected by carbon-13 nuclear magnetic resonance spectroscopy. Chemical Research in Toxicology. 4(6). 678–687. 64 indexed citations
17.
Gallagher, Evan P., Gregory L. Kedderis, & Richard T. Di Giulio. (1991). Glutathione S-transferase-mediated chlorothalonil metabolism in liver and gill subcellular fractions of channel catfish. Biochemical Pharmacology. 42(1). 139–145. 24 indexed citations
18.
Kedderis, Gregory L., et al.. (1989). Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation. Chemical Research in Toxicology. 2(3). 146–149. 33 indexed citations
19.
Kedderis, Gregory L. & Gerald T. Miwa. (1988). The metabolic activation of nitroheterocyclic therapeutic agents. Drug Metabolism Reviews. 19(1). 33–62. 92 indexed citations
20.
Rickert, Douglas E., John P. Chism, & Gregory L. Kedderis. (1986). Metabolism and Carcinogenicity of Nitrotoluenes. Advances in experimental medicine and biology. 197. 563–571. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik J. Søderlund Breakdown of academic impact, for papers by Michael A. Pereira Breakdown of academic impact, for papers by Yasuo Ohno Breakdown of academic impact, for papers by J.A. Beamand Breakdown of academic impact, for papers by Wolfgang W. Huber Breakdown of academic impact, for papers by Charlene A. McQueen Breakdown of academic impact, for papers by William M. Bracken Breakdown of academic impact, for papers by Jos Bessems Breakdown of academic impact, for papers by Matthew Bryant Breakdown of academic impact, for papers by P. Lesca
Rankless by CCL
2026